Name | las191859 |
---|
Description | LAS191859 is an orally active, potent and selective CRTh2 antagonist with an IC50 of 9.58 nM against human CRTh2. LAS191859 can be used for the research of chronic asthma[1]. |
---|---|
Related Catalog | |
Target |
IC50: 7.6 nM (guinea pig CRTh2), 9.58 nM (human CRTh2), 14 nM (rat CRTh2), 15.5 nM (mouse CRTh2)[1] |
References |
Molecular Formula | C24H24F3N3O3 |
---|---|
Molecular Weight | 459.46 |